Nicola Wealth Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-128,500
Closed -$11.1M 125
2022
Q3
$11.1M Sell
128,500
-2,789
-2% -$249K 1.21% 30
2022
Q2
$12M Buy
131,289
+5,000
+4% +$443K 1.14% 31
2022
Q1
$10.4M Sell
126,289
-22,000
-15% -$1.73M 0.91% 43
2021
Q4
$11.4M Hold
148,289
1.07% 35
2021
Q3
$11.1M Sell
148,289
-1,752
-1% -$133K 1.15% 31
2021
Q2
$11.7M Sell
150,041
-16,611
-10% -$1.24M 1.2% 30
2021
Q1
$12.3M Sell
166,652
-17,948
-10% -$1.32M 1.37% 25
2020
Q4
$14.4M Buy
184,600
+66,071
+56% +$5.05M 1.79% 13
2020
Q3
$9.38M Sell
118,529
-6,812
-5% -$534K 1.34% 20
2020
Q2
$9.25M Buy
125,341
+15,720
+14% +$1.18M 1.28% 26
2020
Q1
$9.04M Hold
109,621
1.36% 23
2019
Q4
$10.4M Buy
109,621
+839
+0.8% +$68.9K 1.56% 17
2019
Q3
$9.58M Buy
108,782
+23,265
+27% +$1.86M 1.5% 21
2019
Q2
$7.74M Sell
85,517
-3,982
-4% -$305K 1.28% 32
2019
Q1
$8.18M Hold
89,499
1.22% 31
2018
Q4
$7.6M Sell
89,499
-9,432
-10% -$666K 1.25% 23
2018
Q3
$7.49M Buy
98,931
+9,117
+10% +$581K 1.29% 30
2018
Q2
$5.79M Buy
89,814
+8,594
+11% +$485K 1.12% 30
2018
Q1
$4.22M Buy
+81,220
New +$4.39M 0.85% 50

Other funds holding MRK

Nicola Wealth Management's MRK Position: Q4 2022 in Review

Nicola Wealth Management sold out of Merck (MRK) in Q4 2022, closing a stake of 128,500 shares — an estimated $11.1M sold.

Nicola Wealth Management first reported a position in MRK in Q1 2018 and held it in 19 quarters. The position peaked at $14.4M in Q4 2020. 3,235 funds tracked by Wall St. Rank hold MRK as of Q4 2022.

  • Nicola Wealth Management reported no remaining Merck position as of Q4 2022 after selling out during the quarter.
  • Nicola Wealth Management sold 128,500 Merck shares in Q4 2022, an estimated $11.1M.
  • Nicola Wealth Management first reported a position in Merck in Q1 2018 and held it in 19 quarters.
  • Nicola Wealth Management's Merck position peaked at $14.4M in Q4 2020.
  • 3,235 funds tracked by Wall St. Rank held Merck as of Q4 2022.

Based on Nicola Wealth Management's 13F filing for Q4 2022, filed 9 Feb 2023.